|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
15 August 2016 |
|
Main ID: |
NCT02317263 |
|
Date of registration:
|
03/12/2014 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
December 2014 |
|
Target sample size:
|
0 |
|
Recruitment status: |
Withdrawn |
|
URL:
|
https://clinicaltrials.gov/show/NCT02317263 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
|
|
Phase:
|
Phase 2
|
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria: Men, aged 18-60, with a diagnosis of multiple sclerosis by 2010
revised McDonald Criteria
Age minimum:
18 Years
Age maximum:
60 Years
Gender:
Male
|
|
Health Condition(s) or Problem(s) studied
|
|
Multiple Sclerosis
|
|
Intervention(s)
|
|
Drug: placebo gel
|
|
Drug: testosterone
|
|
Primary Outcome(s)
|
|
Whole Brain Atrophy
[Time Frame: 96 weeks]
|
|
Secondary ID(s)
|
|
U01NS089369
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|